FAQ - CDx : Global Strategy
 

How can companies assess whether their CDx program is truly ready for global development?

 

Many risks in CDx programs only become visible late in development. Structured readiness assessments can help identify gaps in regulatory strategy, clinical evidence planning, assay lifecycle management, and commercialization readiness before they delay submissions or restrict indications.